Clinical Trials · NCT01673984

GP Extended Action Triptorelin

TerminatedPhase 4Gonadorelin (Prohibited)
Phase
Phase 4
Recruitment status
Terminated
Sponsor
Ipsen
Enrollment
27
Start date
Aug 2012
Locations
35 sites, United Kingdom
Primary endpoint
Percentage of Participants Maintaining Biochemical Castration
View Gonadorelin compound reference